BNET Industries
Last Fiscal Year Sales:$127.1M
- Private
- US
Dow Jones Description
Laserscope has all kinds of procedures in its sights. Founded in 1984 and headquartered in San Jose, CA, Laserscope provides laser systems for surgical and cosmetic procedures. The company makes about 300 products for dermatology, urology, ear-nose-throat medicine, cosmetic surgery, obstetrics and gynecology, and photodynamic therapy. They are used for removing varicose veins and unwanted hair, various surgeries, treating prostate problems, and other applications. It sells domestically and internationally, and has distribution arrangements with McKesson. The company had 2005 revenue of about $127.1 million and employs about 300 people. In May 2006, it acquired privately-held InnovaQuartz, a maker and supplier of advanced medical devices.
President & CEO
Eric ReuterNumber of Employees 296
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
News & Analysis
Filter by
fda and laserscope - All News and Analysis
LASERSCOPE GETS FDA CLEARANCE FOR LYRA SYSTEM.
Laserscope (Nasdaq:LSCP), San Jose, Calif, has received 510k clearance from the U.S. Food and Drug Administration to market its innovative LyraTM Laser System for permanent hair reduction on patients with the full range of skin tones from Fitzpatrick Types I - VI. The...
Laserscope
Laserscope, San Jose, Calif., has announced it will submit a pre-market approval application with the U.S. Food and Drug Administration for its photodynamic therapy PDT laser system simultaneous with a new drug application submitted for Foscan[umlaut] by Scotia Pharmaceutials of the UK. The submissions, expected to occur in September,...
Laserscope
Laserscope (San Jose, California) has been granted FDA clearance to market photodynamic therapy PDT for the treatment of late-stage lung cancer. The nonsurgical, minimally invasive therapy combines Laserscope's laser systems with Sanofi Pharmaceuticals' Paris Photofrin, the only PDT drug approved to date in the U.S. In PDT, patients are injected...
Laserscope, Photofrin combination gets FDA cancer treatment clearance
Laserscope, San Jose, Calif., has received FDA clearance for photodynamic therapy using the company's laser systems and the drug Photofrin[umlaut] for the treatment of late-stage lung cancer. The FDA ruling follows unanimous recommendation for approval from the agency's Oncologic Drugs Advisory committee. Specifically, clearance was granted to market...
Laserscope Receives FDA Clearance for Laser Treatment of BPH
SAN JOSE, Calif.--BW HealthWire--Aug. 27, 1998--Laserscope (NASDAQ:LSCP) today announced that it received clearance from the U.S. Food and Drug Administration FDA to market its KTP-based OrionTM, 800 Series and High-Power 800 Series Laser Systems for the treatment of benign prostatic hyperplasia BPH. BPH is a non-cancerous...
Laserscope receives FDA clearance for new higher-power surgical laser system
SAN JOSE, Calif.--BW HealthWire--June 11, 1997--Laserscope (NASDAQ:LSCP) today announced that it received clearance from the U.S. Food and Drug Administration FDA to market a new, higher-power version of its 800 Series Dual-Wavelength KTP/YAGR Surgical Laser System. "We believe that the new higher-power system will add to the...
Laserscope Receives FDA Clearance for Skin Resurfacing, Treatment of Wrinkles and Warts, and Scar Revision
SAN JOSE, Calif.--BW HealthWire--March 5, 1997--Laserscope (NASDAQ:LSCP) today announced that it has received clearance from the U.S. Food and Drug Administration to market its ParaScan Scanning Device and CBH-1 Collimated Beam Handpiece with the Pulsar CO2 Laser System for laser skin resurfacing, laser resurfacing, laserbrasion, the treatment of wrinkles and...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Eric Reuter | President & CEO |
| Dennis Lalumandiere | CFO, Vice President, Finance & Secretary |
| Derek Bertocci | CFO & Vice President, Finance |
| Allan Danto | Vice President |
| Ken Arnold | Vice President |
| Kerrick Securda | Vice President, Global Marketing & Business Development |
| Kester Nahen | Vice President |
| Lloyd Diamond | Vice President, Marketing |
| Peter Hadrovic | Vice President, Legal Affairs and General Counsel |
| Robert Mann | Vice President, Global Sales, Marketing |
| Robert Mathews | Vice President, Operations |
| Van Frazier | Vice President |
| William Kelley | Vice President, Intl Sales & Business Development |
| George Clute | |
| James Baumgardt | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Robert J. Pressley | Chairman |
| Elisha Finney | Board of Directors |
| Robert C. Pearson | Board of Directors |
| Rodney Perkins | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Laserscope | President & CEO | Current |
| Laserscope | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | CFO, Vice President, Finance & Secretary | Current |
| Laserscope | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | CFO & Vice President, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Global Marketing & Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Legal Affairs and General Counsel | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Global Sales, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President | Current |
| Laserscope | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Vice President, Intl Sales & Business Development | Current |
George has over 25 years' experience in the development and financing of emerging growth companies, primarily located in the northwestern United States. He is a founding general partner of OVP Venture Partners (Seattle), the leading institutional venture capital fund based in the northwestern United States with committed capital exceeding US$500 million. Prior experience includes corporate finance and corporate banking positions with The First National Bank of Chicago, Rainier National Bank and with a large equity hedge fund involved in a wide range of investments. George has been involved in the financing of over 200 companies. Historical company involvement includes the following: Advanced Technology Laboratories (acquired); @Mobile (acquired); Coinstar, Inc. (NASDAQ); Data I/O (NASDAQ); Delrina (NASDAQ); Lam Research (NASDAQ); Laserscope (NASDAQ); Logic Automation (acquired); and Xilinx (NASDAQ). George is a past director of numerous companies including Foundstone, Inc. and the Washington Software Alliance and is currently a director of Isothermal Systems Research, Inc. George received his AB and MBA from UCLA.
| Organization | Position | Status |
|---|---|---|
| Banyan Capital Partners | Managing Director | Current |
| OVP Venture Partners | General Partner | Current |
| Foundstone | Past Director | Current |
| Data I/O Corporation | Current | |
| Coinstar, Inc. | Current | |
| The First National Bank of Chicago | Current | |
| Lam Research Corporation | Current | |
| Spraycool | Current | |
| Laserscope | Current | |
| Xilinx, Inc. | Current | |
| Isothermal Systems Research, Inc. | Director | Current |
| University of California, Los Angeles | MBA | Former |
| University of California, Los Angeles | Ab | Former |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Chairman | Current |
| Laserscope | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Board of Directors | Current |
President of Guidant Foundation, Mr. Baumgardt has also been an investor in Suros Surgical Systems since 2001, and the company's non-executive Chairman. He provided leadership to Suros during its $12 million financing in 2004, which was led by Morgan Stanley Venture Partners.
| Organization | Position | Status |
|---|---|---|
| Twilight Venture Partners, LLC | Partner | Current |
| Rose-Hulman Institute of Technology | Trustee | Current |
| Rose-Hulman Institute of Technology | Board of Directors | Current |
| Laserscope | Director | Current |
| Rose-Hulman Institute of Technology | Trustee | Current |
| Eli Lilly and Company | Executive Director of Business Development | Former |
| Guidant Corporation | Executive Director of Business Development | Former |
| Twilight Venture Partners, LLC | Co-Founder | Former |
| Suros Surgical Systems, Inc. | Non-Executive Chairman | Former |
| Suros Surgical Systems, Inc. | Investor | Former |
| Butler University | Masters of Business Administration | Former |
| Rose-Hulman Institute of Technology | Bachelor of Science In Chemical Engineering | Former |
Robert C. Pearson, joined RENN Group in April of 1997 and is Senior Vice President-Investments. He is also Vice-President of the Fund. Mr. Pearson brings more than thirty years of experience to RENN Group's corporate finance function. From May 1994 to May 1997, Mr. Pearson was an independent financial management consultant. From May 1990 to May 1994, he served as Chief Financial Officer and Executive Vice President of Thomas Group Inc. a management consulting firm, where he was instrumental in moving small privately held company from start-up to a public company with more than $40 million in revenues. Prior to 1990, Mr. Pearson was responsible for all administrative activities for the Super Conducting Super Collider Laboratory. In addition, from 1960 to 1985, Mr. Pearson served in a variety of positions at Texas Instruments in financial planning and analysis, holding a BS in Business from the University of Maryland and was a W.A. Paton Scholar with an MBA from the University of Michigan. He is director of eOriginal, Inc., Poore Brothers, Inc., Caminosoft Corp., Laserscope, Simtek Corporation, and Advanced Power Technologies, Inc.
| Organization | Position | Status |
|---|---|---|
| Renaissance Capital Group | Senior Vice President, Investments | Current |
| The Renaissance Group LLC | Senior Vice President | Current |
| Renaissance Capital Growth & Income Fund III, Inc. | Vice President | Current |
| The Original Company, Inc. | Board of Directors | Current |
| Advanced Power Technology, Inc. | Board of Directors | Current |
| Vertical Branding, Inc. | Board of Directors | Current |
| The Inventure Group, Inc. | Director | Current |
| Shea Development Corp. | Board of Directors | Current |
| Caminosoft Corp | Board of Directors | Current |
| Laserscope | Board of Directors | Current |
| Eoriginal, Inc. | Director | Current |
| Simtek Corporation | Board of Directors | Current |
| Thomas Group, Inc. | Chief Financial Officer | Former |
| Thomas Group, Inc. | Executive Vice President | Former |
| Internet Marketing Images, Inc. | Senior Vice President, Investments | Former |
| Texas Instruments Incorporated | Vice President Finance | Former |
| Renaissance Capital Group | Vice President of The Fund | Former |
| Laserscope | Director of one private company | Former |
| University of Michigan | W.A. | Former |
| Simtek Corporation | Chairman | Former |
| University of Michigan | Mba | Former |
| University of Maryland | Bs In Business | Former |
| Organization | Position | Status |
|---|---|---|
| Laserscope | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes



